1. Kjaer SK., Frederiksen K., Munk C., Iftner T. Long-term abcolut risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.// J Natl Cancer Inst. - 2010. - V.102, N 19. - P. 1478-88.
2. Rodriguez AC., Schiffman M., Herrero R. et all. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. // J Natl Cancer Inst. - 2010. - V. 102, N 5. - P. 315- 24.
3. Parkin DMю, Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. // CA Cancer J Clin. - 2005. - V. 55, N 2. - P. 74-108.
4. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. // Int J Cancer. - 2007. - V. 120, N 4. - P. 885-91.
5. Diigiie PA., Rebolj M., Garred P., Lynge E. Immunosuppression and risk of cervical cancer. // Expert Rev Anticancer Ther. - 2013. - V. 13, N 1. - P. 29-42.
6. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2012 г. // М.: Издательская группа РОНЦ, 2014. — 226 с.
7. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. (Internet) 29
8. Kurman RJ., Carcangiu ML., Harrington CS., Young RH, eds. WHO Classification of Tumors of the Female Reproductive Organs. Geneva, Switzerland: WHO Press; 2014. World Health Organization Classification of Tumors. 4th edition.
9. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.// Int J Gynecol Obstet. - 2009. - V. 105, N 2. - P. 103- 4.
10. Wiebea E., Dennyb L., Thomasa G. FIGO cancer report 2012. Cancer of the cervix uteri. // Int J Gynecol Obstet. - 2012. - V. 119, S 2. - P. S100-S109.
11. Hricak H., Gatsonis C., Chi DS. et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651 - Gynecologic Oncology Group 183. // J Clin Oncol. - 2005. - V. 23, N 36. -P. 9329-37.
12. Bipat S., Glas AS, van der Velden J. et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. // Gynecol Oncol. - 2003. - V. 91, N 1. - P. 59-66.
13. Amit A., Schink J., Reiss A. et al. PET/CT in gynecologic cancer: present applications and future prospects--a clinician"s perspective. // Obstet Gynecol Clin North Am. - 2011. - V. 38, N 1. - P. 1-21.
14. Webb JC., Key CR., Qualls CR. et al. Population-based study of microinvasive adenocarcinoma of the uterine cervix. // Obstet Gynecol. - 2001. - V. 97, N 5, Pt 1. - P. 701-6.
15. Elliott P., Coppleson M., Russell P. et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. // Int J Gynecol Cancer. - 2000. - V. 10, N 1. - P. 42-52.
16. Bouchard-Fortier G., Reade CJ., Covens A. Non-radical surgery for small early-stage cervical cancer. Is it time? // Gynecol Oncol. - 2014. - V. 132, N 3. - P. 624-7.
17. Shepherd JH, Spencer C, Herod J, Ind TE. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancercumulative pregnancy rate in a series of 123 women. // BJOG. - 2006. - V. 113, N 6. - P. 719-24.
18. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. // Lancet. - 1997. - V. 350, N 9077. - P. 53540.
19. Sakuragi N., Satoh C., Takeda N. et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. // Cancer. - 1999, - V. 85, N 7. - P. 1547- 54.
20. Huang H., Liu J., Li Y. et al. Metastasis to deep obturator and para-aortic lymph nodes in 649 patients with cervical carcinoma. // Eur J Surg Oncol. - 2011. - V. 37, N 11. -P. 978-83.
21. van Bommel PF., van Lindert AC., Kock HC. et al. A review of prognostic factors in early-stage carcinoma of the cervix (FIGO IB and IIA) and implications for treatment strategy. // Eur J Obstet Gynecol Reprod Biol. - 1987. - V. 26, N 1. - P. 69-84.
22. Peters WA., Liu PY., Barrett RJ. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. // J Clin Oncol. - 2000. - V. 18, N 8. -P. 1606-13.
23. Rotman M., Sedlis A., Piedmonte MR. et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. // Int J Radiat Oncol Biol Phys. - 2006. - V. 65, N 1. - P, 169-76.
24. Sedlis A., Bundy BN., Rotman MZ. et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after 30 radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. // Gynecol Oncol. - 1999. - V. 73, N 2. - P. 177-83.
25. Lintner B., Saso S., Tamai L. et al. Use of abdominal radical trachelectomy to treat cervical cancer greater than 2 cm in diameter. // Int J Gynecol Cancer. - 2013. - V. 23, N 6. - P. 106570.
26. Wethington SL., Sonoda Y., Park KJ. et al. Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters. // Int J Gynecol Cancer. - 2013. - V. 23, N 6. - P. 1092-8.